Schedule 13G ownership disclosure

BOUNDLESS BIO INC

Common Stock, par value $0.0001 per share · CUSIP: 10170A100

Event date: 2025-12-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Nextech VI GP S.a. r.l.

    Shares: 0.00 · Class: 0.0%

  • Nextech VI Oncology SCSp

    Shares: 0.00 · Class: 0.0%

  • Ian Charoub

    Shares: 0.00 · Class: 0.0%

  • Costas Constantinides

    Shares: 0.00 · Class: 0.0%

  • Rocco Sgobbo

    Shares: 0.00 · Class: 0.0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001826420-26-000005
Form type
SCHEDULE 13G/A
Filer
Boundless Bio, Inc.
CIK
CIK 1782303
Filed
Feb 17, 2026
Reporting period
Dec 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub